A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease
Clinical trial NCT07246941 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07246941
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-19
- Primary completion
- 2028-02-28
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.